The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ...
The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some ...
Last year, China-based Jiangsu Hengrui Pharmaceuticals overtook the U.K.’s AstraZeneca as the top clinical trial sponsor in ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.
Healthy people who suffer traumatic spinal injuries are at significantly greater risk for long-term chronic health conditions ...
Swiss pharma giant Novartis has been on a deal spree ahead of several major patent expiries. In late October it agreed a $12 ...
The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback